Recent research highlights GP96’s potential as a promising target for cancer immunotherapy [42,43,44], and its prognostic role is still under investigation in various malignant neoplasms, such as multiple myeloma, glioblastoma, and breast, lung, pancreatic, and gastrointestinal cancers [28]. Here, HSP90B1 is linked to cancer.